{"transactions":[{"id":969060,"issuer":{"id":8104,"kind":"organization","name":"enVVeno Medical Corp","symbol":"NVNO"},"owners":[{"id":71539,"kind":"person","name":"Jenusaitis Matthew","position":1,"cik":"0001357864","reported_name":"Jenusaitis Matthew","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options","published_at":"2025-12-15T20:40:03.000Z","date":"2025-12-11","kind":"grant","planned":false,"acquired":true,"shares":135883,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The common stock options were issued to the Reporting Person on December 11, 2025 pursuant to the Issuer's Amended and Restated 2016 Omnibus Incentive Plan, as amended. The award is subject to time-based vesting and will vest in equal quarterly installments on the last day of each fiscal quarter during the 2026 calendar year."}],"balance_after":135883,"derivative":{"exercise_price":0.325,"expiration_date":"2035-12-11","underlying":"Common Stock","underlying_shares":135883},"source":{"system":"sec-edgar","filing":"0001493152-25-027832","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1357864/000149315225027832/ownership.xml","form_type":"4"}},{"id":1322668,"issuer":{"id":8104,"kind":"organization","name":"enVVeno Medical Corp","symbol":"NVNO"},"owners":[{"id":71539,"kind":"person","name":"Jenusaitis Matthew","position":1,"cik":"0001357864","reported_name":"Jenusaitis Matthew","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-12-23T06:03:16.000Z","date":"2024-12-19","kind":"purchase","planned":false,"acquired":true,"shares":9620,"price":2.53,"value":24338.6,"ownership":{"direct":true},"balance_after":16545,"source":{"system":"sec-edgar","filing":"0001493152-24-051172","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1357864/000149315224051172/ownership.xml","form_type":"4"}},{"id":1323935,"issuer":{"id":8104,"kind":"organization","name":"enVVeno Medical Corp","symbol":"NVNO"},"owners":[{"id":71539,"kind":"person","name":"Jenusaitis Matthew","position":1,"cik":"0001357864","reported_name":"Jenusaitis Matthew","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options","published_at":"2024-12-20T20:33:13.000Z","date":"2024-12-18","kind":"grant","planned":false,"acquired":true,"shares":19752,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The common stock options were issued to the Reporting Person on December 18, 2024 pursuant to the Issuer's Amended and Restated 2016 Omnibus Incentive Plan, as amended (the \"Plan\"). The award is subject to time-based vesting and will vest in equal quarterly installments on the last day of each fiscal quarter during the 2025 calendar year."}],"balance_after":19752,"derivative":{"exercise_price":2.57,"expiration_date":"2034-12-18","underlying":"Common Stock","underlying_shares":19752},"source":{"system":"sec-edgar","filing":"0001493152-24-051145","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1357864/000149315224051145/ownership.xml","form_type":"4"}},{"id":1718913,"issuer":{"id":8104,"kind":"organization","name":"enVVeno Medical Corp","symbol":"NVNO"},"owners":[{"id":71539,"kind":"person","name":"Jenusaitis Matthew","position":1,"cik":"0001357864","reported_name":"Jenusaitis Matthew","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options","published_at":"2023-12-07T17:06:00.000Z","date":"2023-12-05","kind":"grant","planned":false,"acquired":true,"shares":13856,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The common stock options were issued to the Reporting Person on December 5, 2023 pursuant to the issuer's Amended and Restated 2016 Omnibus Incentive Plan, as amended (the \"Plan\"). The award is subject to time-based vesting and will vest in equal quarterly installments on the last day of each fiscal quarter during the 2024 calendar year."}],"balance_after":13856,"derivative":{"exercise_price":3.59,"expiration_date":"2033-12-05","underlying":"Common Stock","underlying_shares":13856},"source":{"system":"sec-edgar","filing":"0001493152-23-044059","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1357864/000149315223044059/ownership.xml","form_type":"4"}},{"id":2097910,"issuer":{"id":8104,"kind":"organization","name":"enVVeno Medical Corp","symbol":"NVNO"},"owners":[{"id":71539,"kind":"person","name":"Jenusaitis Matthew","position":1,"cik":"0001357864","reported_name":"Jenusaitis Matthew","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options","published_at":"2022-12-02T16:30:43.000Z","date":"2022-11-30","kind":"grant","acquired":true,"shares":8403,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The common stock options were issued to the Reporting Person on November 30, 2022 pursuant to the issuer's Amended and Restated 2016 Omnibus Incentive Plan, as amended (the \"Plan\"). The award is subject to time-based vesting and will vest in equal quarterly installments on the last day of each fiscal quarter during the 2023 calendar year."}],"balance_after":8403,"derivative":{"exercise_price":6.7,"expiration_date":"2032-11-30","underlying":"Common Stock","underlying_shares":8403},"source":{"system":"sec-edgar","filing":"0001493152-22-034312","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1357864/000149315222034312/ownership.xml","form_type":"4"}},{"id":2157089,"issuer":{"id":8104,"kind":"organization","name":"enVVeno Medical Corp","symbol":"NVNO"},"owners":[{"id":71539,"kind":"person","name":"Jenusaitis Matthew","position":1,"cik":"0001357864","reported_name":"Jenusaitis Matthew","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2022-09-16T16:05:21.000Z","date":"2022-09-13","kind":"exercise","acquired":false,"shares":1041,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") converts into one share of common stock of enVVeno Medical Corporation."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"On September 13, 2019, the reporting person was granted 3,125 RSUs (78,125 RSUs pre one-for-twenty five (1:25) reverse stock split that was effected in November 2020), subject to vesting and settlement as described in the person's Form 4, as filed on October 10, 2020. The vesting and settlement of the RSUs occurred in September 2020, 2021 and 2022."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"On September 13, 2019, the reporting person was granted 3,125 RSUs (78,125 RSUs pre one-for-twenty five (1:25) reverse stock split that was effected in November 2020), subject to vesting and settlement as described in the person's Form 4, as filed on October 10, 2020. The vesting and settlement of the RSUs occurred in September 2020, 2021 and 2022."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":1041},"source":{"system":"sec-edgar","filing":"0001493152-22-026070","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1357864/000149315222026070/ownership.xml","form_type":"4"}},{"id":2157088,"issuer":{"id":8104,"kind":"organization","name":"enVVeno Medical Corp","symbol":"NVNO"},"owners":[{"id":71539,"kind":"person","name":"Jenusaitis Matthew","position":1,"cik":"0001357864","reported_name":"Jenusaitis Matthew","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-09-16T16:05:21.000Z","date":"2022-09-13","kind":"exercise","acquired":true,"shares":1041,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit (\"RSU\") converts into one share of common stock of enVVeno Medical Corporation."}],"balance_after":6925,"source":{"system":"sec-edgar","filing":"0001493152-22-026070","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1357864/000149315222026070/ownership.xml","form_type":"4"}},{"id":2488292,"issuer":{"id":8104,"kind":"organization","name":"enVVeno Medical Corp","symbol":"NVNO"},"owners":[{"id":71539,"kind":"person","name":"Jenusaitis Matthew","position":1,"cik":"0001357864","reported_name":"Jenusaitis Matthew","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options","published_at":"2021-12-02T16:05:45.000Z","date":"2021-11-30","kind":"grant","acquired":true,"shares":7211,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The common stock options were issued to the Reporting Person on November 30, 2021 pursuant to the issuer's Amended and Restated 2016 Omnibus Incentive Plan, as amended (the \"Plan\"). The award is subject to time-based vesting and will vest in equal quarterly installments on the last day of each fiscal quarter during the 2022 calendar year."}],"balance_after":7211,"derivative":{"exercise_price":6.7,"expiration_date":"2031-11-30","underlying":"Common Stock","underlying_shares":7211},"source":{"system":"sec-edgar","filing":"0001493152-21-030303","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1357864/000149315221030303/ownership.xml","form_type":"4"}},{"id":2568784,"issuer":{"id":8104,"kind":"organization","name":"enVVeno Medical Corp","symbol":"NVNO"},"owners":[{"id":71539,"kind":"person","name":"Jenusaitis Matthew","position":1,"cik":"0001357864","reported_name":"Jenusaitis Matthew","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2021-09-15T21:50:17.000Z","date":"2021-09-13","kind":"exercise","acquired":false,"shares":1042,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") converts into one share of common stock of Hancock Jaffe Laboratories, Inc."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"On September 13, 2019, the reporting person was granted 3,125 RSUs (78,125 RSUs pre one-for-twenty five (1:25) reverse stock split that was effected in November 2020), subject to vesting and settlement as described in the person's Form 4, as filed on October 10, 2020. The vesting and settlement of 1,042 RSUs occurred on September 13, 2021"},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"On September 13, 2019, the reporting person was granted 3,125 RSUs (78,125 RSUs pre one-for-twenty five (1:25) reverse stock split that was effected in November 2020), subject to vesting and settlement as described in the person's Form 4, as filed on October 10, 2020. The vesting and settlement of 1,042 RSUs occurred on September 13, 2021"}],"balance_after":2084,"derivative":{"underlying":"Common Stock","underlying_shares":1042},"source":{"system":"sec-edgar","filing":"0001493152-21-022863","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1357864/000149315221022863/ownership.xml","form_type":"4"}},{"id":2568783,"issuer":{"id":8104,"kind":"organization","name":"enVVeno Medical Corp","symbol":"NVNO"},"owners":[{"id":71539,"kind":"person","name":"Jenusaitis Matthew","position":1,"cik":"0001357864","reported_name":"Jenusaitis Matthew","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-09-15T21:50:17.000Z","date":"2021-09-13","kind":"exercise","acquired":true,"shares":1042,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit (\"RSU\") converts into one share of common stock of Hancock Jaffe Laboratories, Inc."}],"balance_after":5884,"source":{"system":"sec-edgar","filing":"0001493152-21-022863","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1357864/000149315221022863/ownership.xml","form_type":"4"}},{"id":2587829,"issuer":{"id":8104,"kind":"organization","name":"enVVeno Medical Corp","symbol":"NVNO"},"owners":[{"id":71539,"kind":"person","name":"Jenusaitis Matthew","position":1,"cik":"0001357864","reported_name":"Jenusaitis Matthew","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, $$0.00001 par value","published_at":"2021-08-27T15:19:33.000Z","date":"2021-08-25","kind":"purchase","acquired":true,"shares":1300,"price":7.7,"value":10010.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On August 25, 2021, the reporting person purchased 1,300 shares of common stock in the public market at $7.70 per share."}],"balance_after":4842,"source":{"system":"sec-edgar","filing":"0001493152-21-021444","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1357864/000149315221021444/ownership.xml","form_type":"4"}},{"id":2842837,"issuer":{"id":8104,"kind":"organization","name":"enVVeno Medical Corp","symbol":"NVNO"},"owners":[{"id":71539,"kind":"person","name":"Jenusaitis Matthew","position":1,"cik":"0001357864","reported_name":"Jenusaitis Matthew","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option","published_at":"2021-02-22T21:58:04.000Z","date":"2021-02-18","kind":"grant","acquired":true,"shares":5673,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The stock option was granted pursuant to the registrant's Amended and Restated 2016 Omnibus Incentive Plan, as amended (the \"Plan\").."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The common stock options were issued to the reporting person as part of the annual board compensation package for 2021. The award is subject to time-based vesting and will vest in equal quarterly portions over the remainder of the 2021 calendar year."}],"balance_after":5673,"derivative":{"exercise_price":8.2,"expiration_date":"2031-02-18","underlying":"Common Stock","underlying_shares":5673},"source":{"system":"sec-edgar","filing":"0001493152-21-004534","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1357864/000149315221004534/ownership.xml","form_type":"4"}},{"id":3001989,"issuer":{"id":8104,"kind":"organization","name":"enVVeno Medical Corp","symbol":"NVNO"},"owners":[{"id":71539,"kind":"person","name":"Jenusaitis Matthew","position":1,"cik":"0001357864","reported_name":"Jenusaitis Matthew","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2020-10-21T16:05:33.000Z","date":"2020-07-18","kind":"grant","acquired":true,"shares":100000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The common stock options were issued to the Reporting Person pursuant to the Plan on July 18, 2020 as part of the annual board compensation package for 2020. The award is subject to time-based vesting and will vest in equal quarterly portions over the remainder of the 2020 calendar year."}],"balance_after":100000,"derivative":{"exercise_price":0.4,"expiration_date":"2030-07-18","underlying":"Common Stock","underlying_shares":100000},"source":{"system":"sec-edgar","filing":"0001493152-20-019736","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1357864/000149315220019736/ownership.xml","form_type":"4"}},{"id":3001988,"issuer":{"id":8104,"kind":"organization","name":"enVVeno Medical Corp","symbol":"NVNO"},"owners":[{"id":71539,"kind":"person","name":"Jenusaitis Matthew","position":1,"cik":"0001357864","reported_name":"Jenusaitis Matthew","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2020-10-21T16:05:33.000Z","date":"2019-09-13","kind":"grant","acquired":true,"shares":60000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The common stock options were issued to the Reporting Person on September 13, 2019 in connection with joining the Issuer's board of directors pursuant to the Plan. The award is subject to time-based vesting and will vest in equal quarterly portions over a three (3) year period starting from September 13, 2019."}],"balance_after":60000,"derivative":{"exercise_price":2,"expiration_date":"2029-09-13","underlying":"Common Stock","underlying_shares":60000},"source":{"system":"sec-edgar","filing":"0001493152-20-019736","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1357864/000149315220019736/ownership.xml","form_type":"4"}},{"id":3001987,"issuer":{"id":8104,"kind":"organization","name":"enVVeno Medical Corp","symbol":"NVNO"},"owners":[{"id":71539,"kind":"person","name":"Jenusaitis Matthew","position":1,"cik":"0001357864","reported_name":"Jenusaitis Matthew","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2020-10-21T16:05:33.000Z","date":"2019-09-13","kind":"grant","acquired":true,"shares":78125,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Upon vesting, each Restricted Stock Unit (\"RSU\") entitles the Reporting Person to one share of the Issuer's common stock or the cash equivalent, at the discretion of the Issuer."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The RSU were issued to the Reporting Person on September 13, 2019 in connection with joining the Issuer's board of directors pursuant to the Issuer's Amended and Restated 2016 Omnibus Incentive Plan (as amended, the \"Plan\"). The award is subject to time-based vesting and will vest in equal annual portions on: (i) September 13, 2020; (ii) September 13, 2021; and (iii) September 13, 2022."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The RSU were issued to the Reporting Person on September 13, 2019 in connection with joining the Issuer's board of directors pursuant to the Issuer's Amended and Restated 2016 Omnibus Incentive Plan (as amended, the \"Plan\"). The award is subject to time-based vesting and will vest in equal annual portions on: (i) September 13, 2020; (ii) September 13, 2021; and (iii) September 13, 2022."}],"balance_after":78125,"derivative":{"underlying":"Common Stock","underlying_shares":78125},"source":{"system":"sec-edgar","filing":"0001493152-20-019736","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1357864/000149315220019736/ownership.xml","form_type":"4"}},{"id":3001986,"issuer":{"id":8104,"kind":"organization","name":"enVVeno Medical Corp","symbol":"NVNO"},"owners":[{"id":71539,"kind":"person","name":"Jenusaitis Matthew","position":1,"cik":"0001357864","reported_name":"Jenusaitis Matthew","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-10-21T16:05:33.000Z","date":"2020-07-18","kind":"grant","acquired":true,"shares":62500,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":62500,"source":{"system":"sec-edgar","filing":"0001493152-20-019736","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1357864/000149315220019736/ownership.xml","form_type":"4"}}]}